共 50 条
- [32] Bimekizumab safe and effective for AS and PsA in long-term trials [J]. Nature Reviews Rheumatology, 2022, 18 : 494 - 494
- [39] Y Adjuvant treatment with secukinumab induced long term remission in a patient with severe bullous pemphigoid [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 (12): : 1478 - 1480